Evidence map›Paper›PMID 42198330›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Mycoendophytic-Derived Green Resveratrol-Conjugated Silver Nanoparticles Inhibit the Proliferation of Human Epidermoid Carcinoma A-431 Cells.

Amal A Al Mousa, Mohamed E Abouelela, Ahmed A El-Shenawy, M A Abo-Kadoum, Adel Eltoukhy, Youssef Abo-Dahab, Rasha M Allam, Nageh F Abo-Dahab, Abdallah M A Hassane, Mohamed S Refaey

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Unveiling the Pharmacological Potential ofInternational journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amal A Al MousaDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 145111, Riyadh 4545, Saudi Arabia.ORCID 0000-0002-3845-9701
Mohamed E AbouelelaDepartment of Pharmacognosy, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt.ORCID 0009-0006-5226-1503
Ahmed A El-ShenawyDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0003-0875-1602
M A Abo-KadoumBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt.
Adel EltoukhyBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt.
Youssef Abo-DahabDepartment of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco 1700 Fourth St, San Francisco, CA 94158, USA.ORCID 0009-0007-2539-3049
Rasha M AllamPharmacology Department, Medical and Clinical Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.ORCID 0000-0003-2251-8380
Nageh F Abo-DahabBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0002-4793-8528
Abdallah M A HassaneBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0003-0820-8087
Mohamed S RefaeyDepartment of Pharmacognosy, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt.ORCID 0000-0003-3879-104X

Funding

Research Funding Program, King Saud University, Riyadh, Saudi Arabia (ORF- 2025-227)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

A-431 cellsAlternaria alternatacytotoxicityresveratrolsilver nanoparticles

Identifiers

PMID42198330
PMCPMC13209862

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.